CGOF
AVNR

Condorcet Global Opportunity Fund’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Condorcet Global Opportunity Fund’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$1.16M Buy
+68,500
New +$964K 0.48% 30

Other funds holding AVNR

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Condorcet Global Opportunity Fund's AVNR Position: Q4 2014 in Review

Condorcet Global Opportunity Fund opened a new position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q4 2014: 68,500 shares worth $1.16M. The stake represents 0.48% of the portfolio and ranks #30 among its holdings.

166 funds tracked by Wall St. Rank hold AVNR as of Q4 2014.

  • Condorcet Global Opportunity Fund held 68,500 shares of AVANIR PHARMACEUTICALS, INC CL A worth $1.16M as of Q4 2014.
  • AVANIR PHARMACEUTICALS, INC CL A was a new Condorcet Global Opportunity Fund position in Q4 2014.
  • AVANIR PHARMACEUTICALS, INC CL A made up 0.48% of Condorcet Global Opportunity Fund's portfolio in Q4 2014, its #30 holding.
  • 166 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q4 2014.

Based on Condorcet Global Opportunity Fund's 13F filing for Q4 2014, filed 17 Feb 2015.